CN1163242C - Jingan shierkang capsule and its preparing process - Google Patents
Jingan shierkang capsule and its preparing process Download PDFInfo
- Publication number
- CN1163242C CN1163242C CNB001051032A CN00105103A CN1163242C CN 1163242 C CN1163242 C CN 1163242C CN B001051032 A CNB001051032 A CN B001051032A CN 00105103 A CN00105103 A CN 00105103A CN 1163242 C CN1163242 C CN 1163242C
- Authority
- CN
- China
- Prior art keywords
- ganoderma
- endothelium corneum
- gigeriae galli
- corneum gigeriae
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 title abstract 2
- 241000208340 Araliaceae Species 0.000 claims abstract description 17
- 241000222336 Ganoderma Species 0.000 claims abstract description 16
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 16
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 16
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 16
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 16
- 235000008434 ginseng Nutrition 0.000 claims abstract description 16
- 208000019425 cirrhosis of liver Diseases 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 210000003038 endothelium Anatomy 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 239000008176 lyophilized powder Substances 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000007791 liquid phase Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 8
- 210000000952 spleen Anatomy 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 4
- 230000004089 microcirculation Effects 0.000 abstract description 3
- 241000287828 Gallus gallus Species 0.000 abstract description 2
- 241000554432 Isodon amethystoides Species 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 210000004317 gizzard Anatomy 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 230000002787 reinforcement Effects 0.000 abstract 1
- 229940109850 royal jelly Drugs 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 241000256836 Apis Species 0.000 description 9
- 206010003445 Ascites Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 208000019423 liver disease Diseases 0.000 description 3
- 241000256844 Apis mellifera Species 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 241000256846 Apis cerana Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000287826 Gallus Species 0.000 description 1
- 241001489090 Ganoderma japonicum Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 241001365031 Isodon japonicus Species 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention belongs to an oral Chinese patent medicine for treating liver cirrhosis diseases, namely a Jingan shierkang capsule and a preparing method thereof. The present invention is characterized in that the medicine is prepared from the raw materials of the following weight proportion: 10 to 20 of ginseng, 5 to 15 of ganoderma, 2 to 8 of chicken's gizzard membrane, 15 to 25 of notoginseng, 5 to 15 of rabdosia amethystoides and 15 to 70 of royal jelly. The present invention has the functions of great original Qi supplement, Qi replenishment, spleen invigoration, liver nourishment, blood circulation activation, organism immune function reinforcement, microcirculation improvement, etc., and has the effect of liver softness, spleen recovery, heart nourishment and brain strengthening. The medicine is clinically tested by 150 liver cirrhosis patients, and the effective rate reaches above 90%.
Description
Technical field
The invention belongs to a kind of compound capsule for the treatment of hepatopathy and preparation method thereof, particularly relate to a kind of Chinese patent medicine heart tonifying capsule for oral administration for the treatment of the liver cirrhosis disease and preparation method thereof.
Background technology
Liver cirrhosis is that liver is subjected to the result that prolonged and repeated damage causes liver cell degeneration, necrosis, regeneration and a large amount of proliferations of fibrous tissue, and the appearance prompting liver cirrhosis of ascites has belonged to late period.Hepatopathy is a harm greatly of human health, be known as " world's pertinacious disease ", China is the higher country of hepatopathy morbidity, there is every year the hundreds of thousands of them dead because of suffering from liver cirrhosis, hepatocarcinoma, the medical expert attaches great importance to the development of liver cirrhosis, hepatic ascites medicine, but present employed medicine is cured the symptoms, not the disease mostly, easily repeatedly, curative effect is not obvious.Therefore, seek the expectation that a kind of medicine that can effectively treat the liver cirrhosis disease is not only the patient, medical circle is made great efforts one of problem that solves especially.
Summary of the invention
The purpose of this invention is to provide a kind of compound capsule for the treatment of liver cirrhosis, hepatic ascites disease and preparation method thereof.
Solution of the present invention is on the basis of motherland's medical science to the understanding of liver cirrhosis disease and treatment, clinical practice and research in conjunction with surplus 30 years, pick out from motherland's medical treasure-house that reinforcing is set upright, yin fluid astringing is supporing yang, the wholefood and the food plant medicine of strongly invigorating primordial QI, blood circulation promoting and blood stasis dispelling, the liver benefiting spleen invigorating, by the theory of Chinese medical science prescription, skim the cream off milk, make its performance enhancing human body immunity, microcirculation improvement, soft liver fibrosis, recover liver function, effect such as the ascites that disappears.
Heart tonifying capsule of the present invention is made by following component: (consumption is a weight portion)
Radix Ginseng 10-20 Ganoderma 5-15 Endothelium Corneum Gigeriae Galli 2-8
Radix Notoginseng 15-25 Herba Rabdosiae glaucocalycis 5-15 Lac regis apis 15-70
The preparation capsular formula optimization weight of the present invention (part) ratio range is:
Radix Ginseng 12--17 Ganoderma 6--12 Endothelium Corneum Gigeriae Galli 3--6
Radix Notoginseng 16--23 Herba Rabdosiae glaucocalycis 6--12 Lac regis apis 30--57
The capsular optimum weight of the present invention (part) proportioning is:
Radix Ginseng 15 Ganodermas 10 Endothelium Corneum Gigeriae Galli 5
Radix Notoginseng 20 Herba Rabdosiae glaucocalycis 10 Lac regis apis 40
Radix Ginseng of the present invention is meant the cultivation product of Araliaceae Radix Ginseng Panax ginseng C.A.Meg., and the dry root after steaming has that strongly invigorating primordial QI, multiple arteries and veins take off admittedly, the effect of benefiting QI and nourishing blood, the fine powder that the present invention obtains after pulverizing with Radix Ginseng.
Ganoderma among the present invention is the Herb after clean the drying of Polyporaceae plant Ganoderma lucidum (Leyss. Ex Fr.) Karst. Ganoderma japonicum (Fr.) Lioyd.The effect of tranquilizing by nourishing the heart, relieving cough and asthma, benefiting qi and nourishing blood is arranged, also can be used for coronary heart disease, hypertension, hyperlipidemia, hepatitis, tracheitis, and the leukopenia that causes of multiple reason etc.The fine powder that the present invention obtains after pulverizing with Ganoderma.
Endothelium Corneum Gigeriae Galli among the present invention is the cutin inwall of the dry ballast of Phasianidae animal chicken G allus gallus domesticusBrisson, has strengthening the spleen to promote digestion, controlling nocturnal emission with astringent drugs only something lost, treating stranguria calculi dissolving function.The fine powder that the present invention obtains after pulverizing with Endothelium Corneum Gigeriae Galli.
Radix Notoginseng among the present invention is the root of panax araliaceae plant Panax notoginseng (Burk) F.H.Chen, cleans, grinds into fine powder after the drying.Removing stasis to stop bleeding is arranged, the analgesic therapy of invigorating blood circulation, adrenal cortex reinforcing function, regulate carbohydrate metabolism, protect the liver, defying age and antitumor action.
Herba Rabdosiae glaucocalycis among the present invention is the herb of labiate Rabdosia japonica L sodon Glaucocalyx (Maxim) Kudo, the whole intestinal that is good for the stomach is arranged, control inappetence, dyspepsia, but heat-clearing and toxic substances removing, spleen invigorating again, invigorate blood circulation, control gastritis, hepatitis from the beginning of, cold, fever etc.The Herba Rabdosiae glaucocalycis herb that the present invention uses is through fine powder thin clean, that obtain after drying, pulverizing.
Lac regis apis among the present invention is the excretory milky jelly of worker bee glandulae pharyngeae of the insecticide apis cerana Apiscerana Fabricus of honeybee section and the liquid that the Mel configuration forms.Lac regis apis is nutritious, is senior tonic.The function that strengthening by means of tonics, the liver benefiting spleen invigorating are arranged has the enhancing body resistance and promotes growth, promotion hemopoietic function, adjusting cardiac function, adjustment E﹠M function, anticancer, antibiotic, analgesic effect, is life lengthening, anti-senility good merchantable brand.The present invention's Lac regis apis lyophilized powder.
Capsule preparations of the present invention is a raw material with above-mentioned Six-element, and its production method that is prepared into the Chinese medicine capsule employing is:
1, with Radix Ginseng and Radix Notoginseng powder, uses CO
2Supercritical fluid extraction, through decocting liquid, fry in shallow oil after carrying standby;
2, with Herba Rabdosiae glaucocalycis, Ganoderma fine powder, extract 3 times with 70% alcohol heating reflux, each 3 hours, it was standby to merge three extracting solution, and it is standby to reclaim ethanol;
3, Endothelium Corneum Gigeriae Galli thin clean, dry in the shade, be ground into can mistake 200 purpose fine powders standby;
4, it is mixed Radix Ginseng, Radix Notoginseng to be fried in shallow oil the extraction liquid phase of carrying back liquid and Herba Rabdosiae glaucocalycis, Ganoderma, through concentrate, behind the thick paste, mix thoroughly with Endothelium Corneum Gigeriae Galli, Lac regis apis lyophilized powder, drying, mixing, sterilization, after sanitary inspection is qualified, the encapsulated finished product of making 0.5g/ grain ± 10%.
The dosage that the present invention is used for the treatment of is adult every day three times, each 3-5 grain, and be three months a course of treatment, patient can take all the year round.
The present invention has that strongly invigorating primordial QI, replenishing QI to invigorate the spleen, nourishing the liver are invigorated blood circulation, enhancing human body immunity function, microcirculation improvement, can strengthen human body self IL-2, activate NK cell and T, bone-marrow-derived lymphocyte system, can soft liver, multiple spleen, nourish heart, brain-strengthening and have a delicate constitution, disease such as deficiency of both QI and blood, through 150 routine liver cirrhosis clinic trial, effective percentage reaches more than 90%.
Heart tonifying capsule formulation preparation of the present invention is convenient, grow storage period, have no side effect, taking convenience, and it is obvious that liver cirrhosis patient is taken the back curative effect, created new approach for treating the liver cirrhosis disease.
The specific embodiment
Heart tonifying capsule of the present invention takes by weighing raw material (kilogram) by following proportioning:
Radix Ginseng 15 Ganodermas 10 Endothelium Corneum Gigeriae Galli 5
Radix Notoginseng 20 Herba Rabdosiae glaucocalycis 10 Lac regis apis 40
Production method is as follows:
1, with Radix Ginseng and Radix Notoginseng powder, uses CO
2Supercritical fluid extraction, through decocting liquid, fry in shallow oil after carrying standby;
2, with Herba Rabdosiae glaucocalycis, Ganoderma fine powder, extract 3 times with 70% alcohol heating reflux, each 3 hours, it was standby to merge three extracting solution, and it is standby to reclaim ethanol;
3, Endothelium Corneum Gigeriae Galli thin clean, dry in the shade, be ground into can mistake 200 purpose fine powders standby;
4, it is mixed Radix Ginseng, Radix Notoginseng to be fried in shallow oil the extraction liquid phase of carrying back liquid and Herba Rabdosiae glaucocalycis, Ganoderma, through concentrate, behind the thick paste, mix thoroughly with Endothelium Corneum Gigeriae Galli, Lac regis apis lyophilized powder, drying, mixing, sterilization, after sanitary inspection is qualified, the encapsulated finished product of making 0.5g/ grain ± 10%.
Claims (4)
1. a heart tonifying capsule for the treatment of the liver cirrhosis disease is characterized in that it is the medicament of being made by the following weight proportion raw material
Radix Ginseng 10-20 Ganoderma 5-15 Endothelium Corneum Gigeriae Galli 2-8
Radix Notoginseng 15-25 Herba Rabdosiae glaucocalycis 5-15 Lac regis apis 15-70
2. heart tonifying capsule according to claim 1, wherein the weight proportion of each raw material is
Radix Ginseng 12-17 Ganoderma 6-12 Endothelium Corneum Gigeriae Galli 3-6
Radix Notoginseng 16-23 Herba Rabdosiae glaucocalycis 6-12 Lac regis apis 30-57
3. heart tonifying capsule according to claim 1, wherein the weight proportion of each raw material is
Radix Ginseng 15 Ganodermas 10 Endothelium Corneum Gigeriae Galli 5
Radix Notoginseng 20 Herba Rabdosiae glaucocalycis 10 Lac regis apis 40
4. according to the preparation method of the described heart tonifying capsule of claim 1, it is characterized in that:
(1) with Radix Ginseng and Radix Notoginseng fine powder CO
2Supercritical fluid extraction, through decocting liquid, fry in shallow oil after carrying standby;
(2) Herba Rabdosiae glaucocalycis, Ganoderma fine powder are extracted three times with 70% alcohol heating reflux, each three hours, it was standby to merge three extracting solution, and it is standby to reclaim ethanol;
(3) Endothelium Corneum Gigeriae Galli is cleaned, dries in the shade, is ground into to cross 200 purpose fine powders standby;
(4) it is mixed Radix Ginseng, Radix Notoginseng to be fried in shallow oil the extraction liquid phase of carrying back liquid and Herba Rabdosiae glaucocalycis, Ganoderma, through concentrate, behind the thick paste, mix thoroughly with Endothelium Corneum Gigeriae Galli fine powder, Lac regis apis lyophilized powder, drying, mixing, sterilization, after the assay was approved through sanitary standard, the encapsulated finished product of making 0.5g/ grain ± 10%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001051032A CN1163242C (en) | 2000-03-24 | 2000-03-24 | Jingan shierkang capsule and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001051032A CN1163242C (en) | 2000-03-24 | 2000-03-24 | Jingan shierkang capsule and its preparing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1315195A CN1315195A (en) | 2001-10-03 |
| CN1163242C true CN1163242C (en) | 2004-08-25 |
Family
ID=4577530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001051032A Expired - Fee Related CN1163242C (en) | 2000-03-24 | 2000-03-24 | Jingan shierkang capsule and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1163242C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101683437B (en) * | 2008-09-22 | 2012-07-11 | 北京亚东生物制药有限公司 | Traditional Chinese medicine composition for soothing liver and strengthening spleen and nourishing qi and promoting blood circulation and preparation method thereof |
| CN101890111B (en) * | 2009-05-22 | 2012-08-15 | 北京亚东生物制药有限公司 | A traditional Chinese medicine composition for soothing the liver, invigorating the spleen, replenishing qi and activating blood circulation and its preparation method |
| CN105815723A (en) * | 2016-03-24 | 2016-08-03 | 明光市昊昊蜂业有限公司 | Bee milk with effect of removing heat to cool blood |
-
2000
- 2000-03-24 CN CNB001051032A patent/CN1163242C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1315195A (en) | 2001-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1170588A (en) | Pure natural plant human life energy nutritive substrate | |
| CN1047946C (en) | Preparation for treating senile diseases | |
| CN1207041C (en) | Medicine for treating osteoporosis and its preparing process | |
| CN1520737A (en) | Vitamin polysaccharide candy and its process | |
| CN1163242C (en) | Jingan shierkang capsule and its preparing process | |
| CN104489172A (en) | Acanthopanax health tea for improving immunity and preparation method thereof | |
| CN1105557A (en) | Method for preparation of weight-loosing medicine and its products | |
| CN105994867A (en) | Chocolate with effect of improving immunity and preparation method thereof | |
| CN1143516A (en) | Balanced nutritious food-kangfusu and preparing process thereof | |
| CN105902827A (en) | Traditional Chinese medicine composition for improving immunity of human body and preparation method thereof | |
| CN1430982A (en) | Capsule of astragalus and honey as well as its preparing technique | |
| CN1060349C (en) | Menstruation-regulating and speckle-removing capsule and preparation thereof | |
| CN115040610A (en) | Composition and preparation for reducing blood pressure and preparation method | |
| CN1799590A (en) | Deer placenta soft capsule and its preparation method | |
| CN101934046B (en) | Semifluid extract of deer foetus and preparation method thereof | |
| CN1053111C (en) | Chinese medical composite preparation with such functions as dispelling toxicity, detoxicating, recuperating, health preserving and face nursing | |
| CN105853689A (en) | Application of green plum extract to preparation of health care product for treating osteoporosis | |
| CN1259953C (en) | Anti aging health caring medicine | |
| CN1047315C (en) | Chinese medicine powder capsule for eliminating numbness and preparing method thereof | |
| CN1264592A (en) | Medicine for treating ichthyosis and preparing process thereof | |
| CN106173128A (en) | A kind of chocolate with anti-fatigue effect and preparation method thereof | |
| CN1060376C (en) | Chinese medicine preparation for skin diseases | |
| CN1069531C (en) | Chinese medicine compositions and preparation for prevention and treatment of cerebrovascular atherosclerosis and cancer | |
| CN1146434C (en) | Growth promoter for Children | |
| CN1218731C (en) | Chinese medicine for treating dermatopathy and gynecopathy disease and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |